NCT00003331View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients With Advanced Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 1998

Primary Completion Date

November 30, 2001

Conditions
Chronic Myeloproliferative DisordersLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesPrecancerous ConditionUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

fluorouracil

DRUG

leucovorin calcium

DRUG

topotecan hydrochloride

Trial Locations (1)

10016

Kaplan Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

NYU Langone Health

OTHER

NCT00003331 - Combination Chemotherapy in Treating Patients With Advanced Cancer | Biotech Hunter | Biotech Hunter